INTRODUCTION
Human immunodeficiency virus (HIV) infection rates vary across Africa, with the highest adult prevalences in southern and eastern regions (up to approximately 30%) and the lowest rates in northern and western regions (0.1-5.0%).
1 HIV-1 is global, but HIV-2 occurs primarily in West Africa. 2, 3 In Caio', rural Guinea-Bissau, where we performed our cohort study, we observed an increasing prevalence of HIV-1 and a decreasing prevalence of HIV-2. 4 Another study from an urban area in Guinea-Bissau confirmed the trends. 5 Despite characteristics shared with HIV-1, 6 HIV-2 displays differences, such as lower mother to child transmission rates (1-4% vs. 20-40%), lower sexual transmission (1/3 to 1/4 that of HIV-1), lower plasma viral load (0-1000 vs. 10,000-100,000 copies/ml), slower CD4 decline, lower likelihood of progression to AIDS and generally slower progression to AIDS when it does occur (although fast progressors have been described). 6 However, clinical AIDS from HIV-2 is similar to HIV-1 with no substantial difference in mortality. 7 The host genetics of HIV-1 has received considerable attention and reported associations include HLA-B, HLA-C, CCR2, CCR5, CCL5 (RANTES) and CCL3L1 variants. [8] [9] [10] [11] [12] [13] [14] [15] [16] Host genetics of HIV-2 is almost completely unstudied. One study from Senegal described an association of overland to the Laboratório Nacional de Saúde Pública in Bissau, where they were analyzed using FACStrack and SimulSet software (Becton Dickinson, San Jose, CA, USA). FACS results were regarded as invalid if the CD3 % of the two runs were more than 10% different from each other, or if the mean of the two CD3 % was < 45%, or if the sum of CD4 % and CD8 % was more than 10% different from the mean CD3 %.
A second, back-up method for lymphocyte subset measuring was also in place. For this method, 100 μl "TransFix" solution (NEQAS, Sheffield, UK) 24 was added to 500 μl fresh blood and roller-mixed for 5 minutes, after which the sample was kept in a refrigerator at 4 ºC and transported to the MRC Laboratories in Fajara, The Gambia. When the routine method failed, the transfixed samples were stained with fluorochrome-conjugated monoclonal antibodies manually rather than by Q-Prep, and analyzed in the FACScalibur, using the MultiSet software (Becton Dickinson, Erembodegem, Belgium). Results were regarded as invalid if the CD3 % was < 45%, or if the sum of CD4 % and CD8 % was more than 10% different from the mean CD3 %.
In order to investigate whether the results of the two methods (routine and back-up) were comparable, 13 samples were processed using both methods and results compared. The agreement was excellent (r 2 = 0.89 for CD4 %). In addition, a Bland and Altman test 25 was performed to compare the two methods and indicated no difference between them (p = 0.3).
DNA extraction and genotyping. DNA was extracted from the packed blood cells, using Demographic data. Chi square tests were used to compare HIV status by gender, and ttests were used to test for differences in the mean ages of study participants between HIV groups and controls. Age was tested for normality, using both visual inspection and Shapiro-Wilk tests, age did not differ from normality and as a result a t-test was performed.
Dichotomous analyses of HIV groups versus controls. Tests for deviation from Hardy
Weinberg Equilibrium (HWE) were performed using Powermarker software. CD4 count and plasma viral load for HIV-2 analyses. CD4 count (cells/μl) and plasma viral load for HIV-2 (pvlhiv2) (copies/ml) were dichotomized into high and low groups for the analysis of associations within the group of HIV-2 infected subjects. The high and low groups for CD4 were ≥ 500 cells/μl versus < 500 cells/μl; the cut-off for CD4 is the lower limit of normal CD4 counts. The high and low groups for pvlhiv2 were ≥ 1000 copies/ml versus < 1000 copies/ml; this cut-off was based on an earlier study that showed that subjects with a viral load below this threshold (and with a normal CD4 count) had a normal life expectancy, i.e. similar to uninfected controls. 31 These data were analyzed for allele and genotype associations with
Fisher's exact tests using Powermarker.
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RESULTS
Subjects
Of the 547 eligible subjects, 26 subjects died prior to enrollment, two had moved away from the area permanently, 97 subjects were away temporarily, and 15 refused to participate. All remaining 407 subjects gave a medical history and had a physical examination. Of these, 402
provided blood samples. Table 2 , Supplemental Content) showed a difference in age between groups, with the HIV-1 group being significantly younger (p < 0.001). No statistically significant differences were observed between groups with respect to gender.
Dichotomous association analyses (HIV groups 1, 2, and dual infection versus controls)
HWE was tested in controls and there was one significant deviation from HWE at marker rs874627 (p<1.00x10 -3 ). Tests for HWE revealed significant deviations from expected in several, but not all, HIV groups including: rs874627, rs2255301, rs1045261, rs1055141, rs8105483, rs2071081 and rs3213427 (Table 3 , Supplemental Content). Single locus tests identified associations in CD4 at rs2255301, rs2886398, rs11064419, rs874627, rs2071081 with alleles and/or genotypes (Table 2; Table 3 , Supplemental Content).
Additive, dominant and recessive logistic regression models for the SNPs that showed the strongest associations are presented in Table 3 (Table 3) .
Haplotype trend regression analysis revealed a significant 3 marker haplotype association (rs8105483-rs2287886-rs4804803) in CD209 (p = 0.03) with HIV-1 ( 
Analyses of HIV-2 examining CD4 count and plasma viral load in HIV-2 (pvlhiv2)
CD4 count significantly associated with both allelic and genotypic variation at CD209 rs8105483 in patients who were HIV-2 infected (allele p = 0.02 and genotype p = 0.05). In analyses of plasma viral load, CD4 markers rs11575097 (p = 0.03) and rs10849523 (p = 0.02) had significant allelic associations and rs11575097 had a significant genotypic association (p = 0.04).
Haplotype analyses showed a significant association for CD209 rs8105483-rs2287886
(global p = 0.02) ( Table 4) 
DISCUSSION
In the present study we examined eighteen SNPs in two host candidate genes, CD4 and CD209, for association with HIV status, as well as plasma viral load and CD4 count in subjects infected with HIV-2. We observed statistically significant associations between individual CD4 polymorphisms and HIV-2 status, HIV-2 plasma viral load and dual infection (the latter group being small). Although we did not observe evidence for disease status association with single CD209 SNPs, we did observe some evidence for haplotype specific associations in analyses of the HIV-1 infected group compared to control groups (however this was based on small numbers of HIV-1 infecteds). More convincingly, we found evidence for CD4 haplotype frequency differences between HIV-2 individuals with high and low viral load (OR = 2.37, 95%CI [1.35-
CD4 is essential to immune regulation; it acts as an accessory protein for MHC class-II antigen and is involved in T-cell receptor interaction. CD4 is also a primary receptor for both HIV-1 and HIV-2, even if viral isolates of HIV-2 can infect T cells in the absence of CD4, using the chemokine receptor Fusin/CXCR4. 32 There is some evidence that laboratory-adapted CD4-independent HIV-1 infection also exists. 33 Although co-receptors are required for virus entry into the host cell and HIV-2 can use a wider range of co-receptors than HIV-1, 3 given the CD4 receptor's major role, the CD4 gene is an obvious candidate for "susceptibility to HIV infection". Nonetheless, few studies have investigated the role of host genetic variation in CD4.
A recent study examining Kenyan female commercial sex workers 34 In our study, significant associations, both allelic and genotypic, were observed between SNP rs2255301 and infection status ( Table 2 ). This SNP is located in intron 2, < 200 bases from exon 2 and in the boundary with exon 3. Both of these exons encode the amino-terminal D1 domain of CD4, an Ig variable (V)-like domain that binds with high affinity to the gp120 glycoprotein in the viral envelope. 38 Although we did not find evidence for significant LD between rs2255301 and other SNPs we typed around the D1 coding sequence, it is reasonable to hypothesize that rs2255301 is in LD with a functional, but uncharacterised, variation affecting this domain. Our lack of LD in this region is not surprising given the fact that our SNPs in this region are more than 4000 bp from rs2255301. However, an association with high plasma viral load (hence suggesting faster clinical progression) was detected with the rs11575097-rs10849523 G-G haplotype (Table 4) showing signatures of positive selection and those predicting risk has yet to be found. 39 This may be an artefact of how recent the pressure of HIV may be on this gene, the fact that only a minority of the population is exposed, and that different parts of the gene are susceptible to different selection pressures (from one or more infectious agents).
CD209 encodes the dendritic cell-specific ICAM3-grabbing nonintegrin (DC-SIGN), present on both macrophages and dendritic cells (DCs) and it belongs to the C-type lectin receptor family. HIV can subvert DC defense mechanisms and escape immune surveillance, allowing the virus to enter T cells, thus leading to infection of these cells. 40 Reports have associated variation in CD209 with HIV-1 susceptibility, but findings from different studies and different ethnic groups are inconsistent and comparative genomics data from chimpanzees are unsupportive.
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The CD209 role in transporting the virus via immature DCs from the periphery to lymph nodes, where CD4 cells would be activated and infected, could explain a link between CD209 genetic variation and CD4 count. In our dataset the rs8105483-rs2287886 (in LD, Figure 2 , Supplemental Content) G-G haplotype was associated with protection from disease (i.e. with "high" CD4 count; p = 0.03) however the "low count" CD4 subset was based on only five subjects carrying the G-A risk haplotype while no G-A were observed in the "high count" group.
Given the small numbers no clear conclusion can be drawn.
Although we did not explicitly correct for multiple tests for single SNPs we did calculate empirical p-values by using permutation testing of haplotypes; similar size effect and level of significance were detected when haplotypes included positively associated single SNPs. This suggests that, despite no correction for multiple testing for single markers, the results are reliable and merit follow-up. CD4 rs874627 deviated from HWE in controls, however, this SNP was not part of the haplotype associated with viral load in the HIV-2 group.
This study implicates CD4 as susceptibility gene for HIV-2 infection in West Africans
from Guinea-Bissau and, to our knowledge, is the first study examining the role of CD4 and CD209 variants in HIV-2 infection. The effect of CD4 polymorphisms in our HIV-2 cohort, in addition to the association reported in the HIV-1 cohort from Kenya, 31 suggests that sequence variation in CD4 plays a role at a fundamental biological level in the interaction between HIV CD4 SNPs associate with HIV-2 infection in Guinea-Bissau (final version) 15 and host and that there may be some commonality in HIV-1 and HIV-2 susceptibility.
Elucidation of the precise role this gene plays in HIV susceptibility depends on isolating functional variants that may explain the phenotypic effect. 2 Plasma viral load: ≥ 1000 copies/ml (high) versus < 1000 copies/ml (low) *In bold are all statistically significant associations (p ≤ 0.05) **Also significant was the three marker haplotype consisting of rs11575097-rs10849523-rs3782736 (p = 0.009), however, this was not the strongest window and therefore those results are not presented. in one of the HIV groups: rs874627 (control group p < 1.00x10 -3 ; HIV-1 p = 0.002: HIV-2 p < 1. 
Supplemental
